The use of an innovative anti-mycotoxin agent to mitigate the adverse effects of aflatoxin B1 in broiler chickens

Insaf Riahi1, Antonella Della Badia1, Raquel Codina1, Diego Sturza2, Leandro Giacomini2, Carlos Mallman3

1Technical Department, BIŌNTE Nutrition S.L., Reus (Spain); 2Instituto Samitec, Santa Maria (Brazil); 3Universidade Federal de Santa Maria, Laboratório de Análises Micotoxicológicas, Santa Maria, Rio Grande do Sul (Brazil)

INTRODUCTION

Aflatoxin B1 (AFB1) represents the predominant mycotoxin that negatively impairs broilers health and production. The detrimental effects on health described in this species involve intestinal damage, oxidative stress and altered immune system (Sarker et al., 2023). Thus, the mitigation of those detrimental effects is essential to ensure animal welfare and production.

OBJECTIVE

This study aims to evaluate the efficacy of an anti-mycotoxin agent (AMA), containing selected binding material combined with natural extracts and yeasts, in improving animal performance and mitigating the intestinal epithelium damage induced by AFB1 in broilers chickens.

MATERIALS & METHODS

RESULTS

CONCLUSIONS

The innovative anti-mycotoxin agent containing selected binding material combined with natural extracts and yeast, enhanced animal performance and improved the gut integrity in broiler chickens challenged by AFB1.